Skip to main content
. 2021 Aug 13;2021:5265379. doi: 10.1155/2021/5265379

Table 5.

Antibiotic resistance patterns of Gram-negative bacteria isolated from patients with infections.

Antibiotics E. coli Klebsiella spp. Enterobacter spp. P. aeruginosa Acinetobacter spp. S. maltophilia Other NFB Proteus spp.
R% I% S% R% I% S% R% I% S% R% I% S% R% I% S% R% I% S% R% I% S% R% I% S%
Ceftizoxime 53.6 8.6 37.8 52.0 2.8 45.2 37.1 6.4 56.4 NA NA NA NA NA NA NA NA NA NA NA NA 11.1 1.6 87.3
Amikacin 5.3 5 89.6 22.6 2.4 75.0 8.0 6.4 85.5 9.9 1.4 88.7 95.7 2.7 1.6 8.3 0 91.7 44.4 0 55.6 0 0 100
Cefixime 63.7 1.4 34.9 54.4 2.0 43.5 48.4 4.8 46.8 NA NA NA NA NA NA NA NA NA NA NA NA 12.7 4.8 82.5
Ciprofloxacin 54.9 6.4 38.7 30.6 6.8 62.5 14.5 4.8 80.6 15.5 0 84.5 98.9 0.5 0.5 4.2 0 95.8 11.1 22.2 66.7 28.6 6.3 65.1
Nitrofurantoin 18.7 12.0 69.2 68.5 23.0 8.5 69.3 6.4 24.2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA
Gentamicin 27.0 0.9 72.1 28.2 0.4 71.3 21.0 0 79.0 9.9 0.7 89.4 94.6 1.1 4.3 8.3 0 91.7 44.4 0 55.6 6.3 0 93.6
Nalidixic acid 69.8 2.7 27.5 35.1 10.1 54.8 35.5 8.0 56.4 NA NA NA NA NA NA NA NA NA NA NA NA 52.4 0 47.6
Ceftriaxone 64.0 0.9 35 37.1 5.6 57.3 32.3 6.4 61.3 NA NA NA 69.7 1.6 28.6 NA NA NA NA NA NA 7.9 11.1 80.9
SXT 66.2 0.3 33.5 47.2 4.0 48.8 30.6 3.2 66.1 NA NA NA 96.8 1.6 1.6 8.3 0 91.7 27.8 0 72.2 65.1 0 34.9
Norfloxacin 56.8 3.2 40 27.8 1.2 71.0 21.0 0 79.0 27.5 0 72.5 NA NA NA NA NA NA NA NA NA 23.8 0 76.2
Tetracycline 63.7 0.6 35.7 38.3 12.1 49.6 33.9 9.7 56.4 NA NA NA 73.0 3.2 23.8 16.7 0 83.3 55.6 5.6 38.9 NA NA NA
Chloramphenicol 24.7 8.6 66.6 32.7 4.0 63.3 24.2 9.7 66.1 NA NA NA NA NA NA 0 8.3 91.7 61.1 22.2 16.7 41.3 17.5 41.3
Imipenem 41.0 20.0 39.0 40.3 16.9 42.7 25.8 8.0 66.1 15.5 9.1 75.3 99.5 0 0.5 66.7 8.3 25.0 50.0 16.7 33.3 NA NA NA
Colistin 6.8 0 93.2 1.2 0 98.8 6.4 0 93.5 0 0 100 0 0 100 12.5 0 87.5 44.4 0 55.6 NA NA NA

R: resistant, I: intermediate, S: sensitive, SXT: Co-Trimoxazole, NFB: nonfermentative bacteria, and NA: not applicable.